CYP2C19 loss-of-function alleles are not associated with clinical outcome of clopidogrel therapy in patients treated with newer-generation drug-eluting stents

CYP2C19 loss-of-function (LOF) alleles adversely affect clinical outcome of clopidogrel therapy. Recent introduction of a newer-generation drug-eluting stent (DES) has significantly reduced the occurrence of stent thrombosis. The aim of this study was to evaluate the impact of CYP2C19 LOF alleles on...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Choi, Ik Jun, Koh, Yoon-Seok, Park, Mahn-Won, Her, Sung Ho, Choi, Yun-Seok, Park, Chul-Soo, Park, Hun-Jun, Kim, Pum-Joon, Chung, Wook-Sung, Kim, Ho-Sook, Shin, Jae-Gook, Seung, Ki-Bae, Chang, Kiyuk
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2016
Assuntos:
3400
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4937952/
https://ncbi.nlm.nih.gov/pubmed/27368038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000004049
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados